Cargando…

Triglycerides and leptin soluble receptor: Which one is the target to protect β-cells in patients with type 2 diabetes?

OBJECTIVES: to study the relationships of leptin and leptin SR with adiposity indices, and glycemic indices in patients with type 2 diabetes mellitus (T2DM) compared to healthy subjects. METHODS: This cross-sectional study involved 65 patients with T2DM and 63 healthy controls. Fasting plasma levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzamil, Hana, Aldokhi, Laila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027012/
https://www.ncbi.nlm.nih.gov/pubmed/36950695
http://dx.doi.org/10.3389/fendo.2023.1077678
_version_ 1784909636224155648
author Alzamil, Hana
Aldokhi, Laila
author_facet Alzamil, Hana
Aldokhi, Laila
author_sort Alzamil, Hana
collection PubMed
description OBJECTIVES: to study the relationships of leptin and leptin SR with adiposity indices, and glycemic indices in patients with type 2 diabetes mellitus (T2DM) compared to healthy subjects. METHODS: This cross-sectional study involved 65 patients with T2DM and 63 healthy controls. Fasting plasma levels of leptin, leptin SR, insulin and lipid profile were measured by enzyme linked immunosorbent essay, basal insulin resistance and beta-cell function were assessed using the homeostasis model assessment. RESULTS: leptin SR level was significantly higher in T2DM patients than in controls (5.8 ± 1.6 and 4.8 ± 1.3 respectively; p= 0.001). In patients with T2DM, leptin SR was negatively correlated with homeostasis model of β-cell function and body fat mass while it has a significant positive correlation with glycosylated hemoglobin (HbA1c). The independent predictors for leptin SR in patients with T2DM were triglycerides (TG) and HbA1c. CONCLUSIONS: elevated serum leptin SR level in patients with T2DM was positively correlated with TG and abnormal glucose metabolism which indicate that it plays a role in pathophysiology of T2DM. The association of elevated leptin SR level with high TG and deterioration of β-cell function indicate that in some individuals, particularly non-obese, dyslipidemia might be a cause rather than a complication of diabetes.
format Online
Article
Text
id pubmed-10027012
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100270122023-03-21 Triglycerides and leptin soluble receptor: Which one is the target to protect β-cells in patients with type 2 diabetes? Alzamil, Hana Aldokhi, Laila Front Endocrinol (Lausanne) Endocrinology OBJECTIVES: to study the relationships of leptin and leptin SR with adiposity indices, and glycemic indices in patients with type 2 diabetes mellitus (T2DM) compared to healthy subjects. METHODS: This cross-sectional study involved 65 patients with T2DM and 63 healthy controls. Fasting plasma levels of leptin, leptin SR, insulin and lipid profile were measured by enzyme linked immunosorbent essay, basal insulin resistance and beta-cell function were assessed using the homeostasis model assessment. RESULTS: leptin SR level was significantly higher in T2DM patients than in controls (5.8 ± 1.6 and 4.8 ± 1.3 respectively; p= 0.001). In patients with T2DM, leptin SR was negatively correlated with homeostasis model of β-cell function and body fat mass while it has a significant positive correlation with glycosylated hemoglobin (HbA1c). The independent predictors for leptin SR in patients with T2DM were triglycerides (TG) and HbA1c. CONCLUSIONS: elevated serum leptin SR level in patients with T2DM was positively correlated with TG and abnormal glucose metabolism which indicate that it plays a role in pathophysiology of T2DM. The association of elevated leptin SR level with high TG and deterioration of β-cell function indicate that in some individuals, particularly non-obese, dyslipidemia might be a cause rather than a complication of diabetes. Frontiers Media S.A. 2023-03-06 /pmc/articles/PMC10027012/ /pubmed/36950695 http://dx.doi.org/10.3389/fendo.2023.1077678 Text en Copyright © 2023 Alzamil and Aldokhi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Alzamil, Hana
Aldokhi, Laila
Triglycerides and leptin soluble receptor: Which one is the target to protect β-cells in patients with type 2 diabetes?
title Triglycerides and leptin soluble receptor: Which one is the target to protect β-cells in patients with type 2 diabetes?
title_full Triglycerides and leptin soluble receptor: Which one is the target to protect β-cells in patients with type 2 diabetes?
title_fullStr Triglycerides and leptin soluble receptor: Which one is the target to protect β-cells in patients with type 2 diabetes?
title_full_unstemmed Triglycerides and leptin soluble receptor: Which one is the target to protect β-cells in patients with type 2 diabetes?
title_short Triglycerides and leptin soluble receptor: Which one is the target to protect β-cells in patients with type 2 diabetes?
title_sort triglycerides and leptin soluble receptor: which one is the target to protect β-cells in patients with type 2 diabetes?
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027012/
https://www.ncbi.nlm.nih.gov/pubmed/36950695
http://dx.doi.org/10.3389/fendo.2023.1077678
work_keys_str_mv AT alzamilhana triglyceridesandleptinsolublereceptorwhichoneisthetargettoprotectbcellsinpatientswithtype2diabetes
AT aldokhilaila triglyceridesandleptinsolublereceptorwhichoneisthetargettoprotectbcellsinpatientswithtype2diabetes